Related Experiment Videos
Management of the premature infant with a patent ductus arteriosus
Pediatric Clinics of North America
|December 1, 1984
Insights
Premature infants often face lung maturation challenges. This article details patent ductus arteriosus (PDA) in premature infants, covering its clinical signs, pathophysiology, and management strategies.
Area of Science:
- Neonatology
- Pediatric Cardiology
- Respiratory Medicine
Background:
- Lung maturation is a critical challenge for premature infants.
- Premature infants exhibit a higher incidence of patent ductus arteriosus (PDA).
- PDA in neonates presents significant clinical and management challenges.
Purpose of the Study:
- To discuss the clinical manifestations of PDA in premature infants.
- To explain the pathophysiologic basis of PDA in this population.
- To outline current management strategies for PDA in premature neonates.
Main Methods:
- Literature review of clinical studies and pathophysiologic research.
- Analysis of diagnostic criteria and therapeutic approaches.
- Synthesis of information on PDA management in premature infants.
Main Results:
- PDA is common in premature infants, linked to immature lung development.
- Clinical signs include respiratory distress and cardiac murmurs.
- Management involves medical and surgical interventions tailored to infant condition.
Conclusions:
- Understanding PDA's clinical and pathophysiologic aspects is crucial for neonatologists.
- Effective management requires a multidisciplinary approach.
- Timely intervention can improve outcomes for premature infants with PDA.
Abstract:
The maturation of the lung is one of the greatest challenges the premature infant must face after birth. Premature infants have been observed to have a higher prevalence of patency of the ductus arterious, presenting the physician with a dilemma and a challenge. This article discusses the clinical and pathophysiologic manifestations and the management of patent ductus arteriosus in the premature infant.